These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15191121)

  • 1. Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a Northern Alberta population.
    Bowker SL; Soskolne CL; Houston SC; Newman SC; Jhangri GS
    Can J Public Health; 2004; 95(3):188-92. PubMed ID: 15191121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for hepatitis c virus co-infection among human immunodeficiency virus-infected patients and effect of hepatitis c virus infection on acquired immunodeficiency syndrome cases at baseline.
    Yakubu A; Hali B; Maiyaki AS
    Ann Afr Med; 2021; 20(4):297-301. PubMed ID: 34893569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and correlates of HIV and HCV among injecting drug users in Edmonton, Alberta.
    Plitt SS; Gratrix J; Hewitt S; Conroy P; Parnell T; Lucki B; Pilling V; Anderson B; Choudri Y; Archibald CP; Singh AE
    Can J Public Health; 2010; 101(1):50-5. PubMed ID: 20364539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.
    Hsieh MH; Tsai JJ; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Yu ML; Chuang WL
    PLoS One; 2014; 9(4):e94791. PubMed ID: 24722534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross sectional study of factors associated to self-reported blood-borne infections among drug users.
    Reyes-Urueña J; Brugal MT; Majo X; Domingo-Salvany A; Caylà JA
    BMC Public Health; 2015 Nov; 15():1122. PubMed ID: 26566634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of hepatitis C co-infection in recently HIV-infected minority men who have sex with men in Los Angeles: a cross-sectional study.
    Chew KW; Blum ML; Javanbakht M; Clare LE; Bornfleth LD; Bolan R; Bhattacharya D; Gorbach PM
    BMC Infect Dis; 2015 Nov; 15():538. PubMed ID: 26590028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal.
    Shrestha LB; Yadav GK; Pradhan S; Sharma A; Pandit T; Chhetry R; Khanal B
    PLoS One; 2022; 17(3):e0264791. PubMed ID: 35239716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.
    Larsen C; Pialoux G; Salmon D; Antona D; Le Strat Y; Piroth L; Pol S; Rosenthal E; Neau D; Semaille C; Delarocque Astagneau E
    Euro Surveill; 2008 May; 13(22):. PubMed ID: 18761958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
    AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.